Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Curcumin, a phytochemical, demonstrates significant anticancer properties, particularly in prostate cancer.
• MicroRNA-34a (miR-34a) is recognized as a key tumor suppressor miRNA involved in regulating cancer cell growth.
• The specific role of miR-34a in curcumin's anticancer mechanism against prostate cancer remains under-investigated.

Purpose of the Study:

• To investigate the role of miR-34a in the antiproliferative effects of curcumin on prostate cancer cells.
• To elucidate the molecular mechanisms by which curcumin affects prostate cancer cell proliferation, focusing on miR-34a and associated signaling pathways.

Main Methods:

• Prostate cancer cell lines were treated with curcumin.
• Gene expression analysis was performed to assess levels of miR-34a, cell cycle-related genes (cyclin D1, PCNA, p21), β-catenin, and c-myc.
• Functional assays were conducted to evaluate the impact of miR-34a inhibition on curcumin's antiproliferative activity.

Main Results:

• Curcumin inhibited prostate cancer cell proliferation and altered the expression of cell cycle-related genes.
• Curcumin significantly upregulated miR-34a expression while downregulating β-catenin and c-myc.
• Inhibition of miR-34a reactivated the β-catenin/c-myc pathway, reversed cell cycle gene alterations, and diminished curcumin's antiproliferative effect.

Conclusions:

• miR-34a is a critical mediator of curcumin's antiproliferative action in prostate cancer.
• Curcumin exerts its anticancer effects, at least in part, by upregulating miR-34a, which subsequently suppresses the β-catenin/c-myc signaling pathway.
• These findings highlight miR-34a as a potential therapeutic target for enhancing curcumin-based prostate cancer treatments.